封面
市場調查報告書
商品編碼
1198374

智能醫療設備市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

Smart Medical Devices Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

智能醫療設備市場預計在預測期內 (2022-2027) 的複合年增長率為 7.5%。

在 COVID-19 大流行期間,傳感器和納米生物傳感器等智能醫療設備對於非接觸式醫療保健診斷具有相當大的重要性。 可穿戴傳感器可以測量人體的重要信號,如心率、血壓、膚色、體溫、呼吸頻率、睡眠時間和身體運動。 2021 年 4 月,倫敦帝國理工學院和弗萊堡大學的研究人員將建立一個患者健康數據網絡,並開發一種可穿戴設備,即使患者沒有症狀,也可以對 COVID-19 進行早期診斷。據報導,

智能醫療設備市場的推動因素包括對智能手機和無線醫療設備的需求不斷增長、設備技術進步以及人們對健身的認識和關注度不斷提高。

對傳感器、ECG 設備和帶健身追蹤器的智能手錶等可穿戴醫療設備的需求正在增加,因為這些設備易於使用,不需要高度專業知識來解釋結果。 因此,用戶無需經常去診所/醫院就診即可監測自己的生命體徵並了解自己的健康狀況。 可穿戴醫療設備的這些特性有望提高老年人的接受度。

此外,根據聯合國2022年7月公佈的《2022年世界人口展望》更新的數據,2022年歐洲和北美將是老齡化最嚴重的地區,65歲及以上人口將達到19%左右。據說 另外,根據聯合國經濟和社會事務部的公告。 根據人口部 2022 年 7 月更新的數據,截至 2020 年 1 月,荷蘭總人口中有 15.6% 超過 65 歲,有 2,686,541 人超過 64 歲,其中男性 116 人,7,896 人,和 1,518,645 名女性。

血糖、心率和 ECG 等測量值需要通過設備上的簡單導航按鈕或連接的移動應用程序進行配置,讓老年人和非技術人員也能輕鬆使用。

主要參與者正在大力投資研發新的和現有的可穿戴醫療設備。 例如,Apple 在過去幾年推出了手錶系列 1、2、3、4、5 和 6。 通過系列 1 到系列 6 中可用的功能可以見證技術進步。 系列 1、2 和 3 具有光學心臟傳感器(高心率通知)、光學心臟傳感器(低心率通知)和光學心臟傳感器(心律失常通知)等功能。

在印度和南非等新興國家,人們的生活方式導致疾病,人們正在努力與之抗爭。 因此,未來先進智能醫療設備的市場有望擴大。

智能醫療設備的市場趨勢

胰島素泵預計在預測期內市場增長顯著

胰島素泵是一種用於給糖尿病患者註射胰島素的醫療設備。 胰島素泵由泵、一次性儲液器和一次性輸液器組成。 水泵部分由控制器、處理模塊和電池組成。 一次性儲液器將胰島素裝在泵中。 一次性輸液器由插管和將胰島素儲液器連接到插管的管路系統組成。 胰島素泵相對容易攜帶,並且由於它們可以準確地測量要給藥的胰島素量,因此可以消除劑量浪費並確保為患者正確給藥。 胰島素泵的智能機制將為糖尿病患者帶來巨大的福音。

在這個市場細分領域,公司正在專注於他們的產品開發策略。 例如,2022年7月,美敦力在印度推出了MiniMed 780G系統。 MiniMed 780G 是下一代閉環胰島素泵系統,用於治療 7 至 80 歲的 1 型糖尿病。 之後,2020年9月,美敦力基於670G系統構建的胰島素泵系統“Minimed 770G”獲得美國食品藥品監督管理局的批准。 770G 具有智能手機連接功能,並包含適用於 2 歲及以上兒童的適應症。 因此,由於上述使用胰島素泵的好處和全球糖尿病患病率的增加,預計胰島素泵行業將在預測期內實現增長。

北美有望在預測期內主導市場

按地區劃分,北美佔據最大的市場份額,預計在預測期內將繼續如此。 北美的醫療保健設施是最高標準的,並不是所有人都可以使用,但是有優惠的政策可以確保很多人都能獲得醫療保健。我可以。 正因為如此,您可以在全國范圍內獲得更高的銷售率。 不斷進步的技術進步和先進醫療設備的早期採用率正在推動該地區智能醫療設備市場的顯著增長。

美國心臟協會 2021 年心髒病和中風統計數據更新情況說明書發現冠心病 (CHD) 是美國 (42.1%) 心血管死亡的主要原因。 因此,美國人口中的慢性病增加了對智能醫療設備和家庭患者監護設備的需求,推動了研究市場的增長。

此外,Garmin Ltd、Fitbit, Inc 和 Biotelemetry, Inc 等研究市場的主要參與者大多集中在該地區,智能醫療設備的研發在該地區推出創新產品. 投資了 例如,2020 年 8 月,Fitbit, Inc. 推出了 Fitbit Sense,這是一款先進的健康智能手錶,可通過測量皮膚電活動反應來幫助檢測身體對壓力源的反應。 因此,鑑於事實,所研究的市場預計在預測期內在北美將顯著增長。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 對與智能手機兼容的醫療設備和無線醫療設備的需求增加
    • 設備的技術進步
    • 健身意識不斷增強
  • 市場製約因素
    • 設備成本高
    • 患者隱私保護
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品類型
    • 通過診斷和監測
      • 血糖監測儀
      • 心率監測器
      • 脈搏血氧計
      • 血壓計
      • 呼吸分析儀
      • 其他監控設備
    • 通過治療設備
      • 便攜式製氧機/呼吸機
      • 胰島素泵
      • 助聽器
      • 其他治療設備
  • 最終用戶
    • 醫院/診所
    • 家庭護理
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Apple Inc.
    • BIO-BEAT
    • Dexcom Inc.
    • F. Hoffmann-La Roche Ltd
    • Fitbit Inc.
    • Medtronic PLC
    • NeuroMetrix Inc.
    • Omron Corporation
    • Otsuka Holdings CO. LTD
    • Koninklijke Philips N.V.
    • Vital Connect
    • Samsung

第7章 市場機會今後動向

簡介目錄
Product Code: 64189

The smart medical devices market is expected to register a CAGR of 7.5% during the forecast period (2022-2027).

During the COVID-19 pandemic, smart medical devices, including sensors and nano-bio sensors, have gained considerable importance due to contactless-based healthcare diagnosis. The wearable sensors can measure vital signals of the human body such as heart rate, blood pressure, skin coloration, body temperature, respiratory rate, sleep duration, and body motion. In April 2021, Researchers at Imperial College London and the University of Freiburg reported that they were developing wearable devices that could be used to develop a network of health data about a patient, allowing for early diagnosis of COVID-19 even when the patient is asymptomatic.

The smart medical devices market is driven by the rising demand for smartphone-compatible and wireless medical devices, technological advancements in devices, and rising awareness and focus on fitness.

The demand for wearable medical devices, such as sensors, ECG devices, and smartwatches with fitness trackers has increased because these devices are easy to use, and interpreting the results doesn't need great expertise. Thus, the user can keep track of their health condition by monitoring their vital signs without the need to visit clinics/hospitals frequently. This feature of wearable medical devices is expected to witness an increased acceptance among the geriatric population.

Additionally, the data updated by United Nations in its World Population Prospectus 2022 published in July 2022 mentioned that Europe and Northern America had the oldest population in 2022, with almost 19% population aged 65 or over. In addition, as per the United Nations Department of Economic and Social Affairs: Population Division data updated in July 2022 shows that as of January 2020, 15.6% of the total population in the Netherlands are of age 65 or more, which were 2,686,541 persons above 64 years old were there in the country among which 1,167,896 were males, and 1,518,645 were females.

The measurement of blood glucose levels, heart rate, and ECG require the users to use simple navigation buttons on the device or control the settings through a connect mobile application, thus making the use of these devices comfortable for the elderly and people with low technology acumen.

The key players have invested heavily in the research and development of new and existing wearable medical devices. For instance, Apple has launched Watch Series 1,2,3,4,5, and 6 over the past few years. The technological advancements can be witnessed through the features available in series 1 to series 6. Apple watch series 1, 2, and 3 possess features such as an optical heart sensor (high heart rate notification), optical heart sensor (low heart rate notification), and optical heart sensor (irregular rhythm notification).

The lifestyle of the people across developing countries such as India, South Africa, etc., are making them fall prey to the diseases, and hence, efforts are being made by these people to cope with such diseases. Therefore, it is believed that the market for advanced smart medical devices will grow in the coming future.

Smart Medical Devices Market Trends

Insulin Pumps are Expected to Witness Good Growth in the Market Over the Forecast Period

An insulin pump is a medical device used for administrating insulin in diabetic patients. The insulin pump consists of a pump, a disposable reservoir, and a disposable infusion set. The pump part consists of controls, a processing module, and batteries. The disposable reservoir holds the insulin inside the pump. The disposable infusion set consists of a cannula and a tubing system to connect the insulin reservoir to the cannula. Insulin pumps are relatively easy to carry and measure the exact quantity of insulin to be delivered, reducing the wastage of doses and achieving proper insulin delivery to the patients. The smart mechanism of insulin pumps is a great boon to the world of diabetes.

The market players in this segment are focusing on product development strategies. For instance, In July 2022, Medtronic launched MiniMed 780G system in India. The Minimed 780G is a next-generation closed-loop insulin pump system for treating type 1 diabetes in people aged seven to 80. Later in September 2020, Medtronic received United States Food and Drug Administration approval for its MiniMed 770G insulin pump system built on the 670G system. The 770G features smartphone connectivity and is embedded with indications for ages 2 and above. Thus, owing to the advantages mentioned above of using insulin pumps and the increasing prevalence of diabetes worldwide, the insulin pump segment is expected to register growth over the forecast period.

North America is Expected to be the Major Contributor in the Market Over the Forecast Period

Regionally, North America held the largest market share and is expected to do so even in the forecast period. The healthcare facilities in North America are of the highest standards and are accessible to the large population because of favorable policies making healthcare affordable to many, if not all. This helps in gaining a higher selling rate across the country. The increase in technological advancements and the high early adoption of advanced medical devices have been the driving factors for the significant growth of this region's smart medical devices market.

As per the American Heart Association 2021 heart disease and Stroke Statistics Update fact Sheet, Coronary Heart Disease (CHD) was the leading cause (42.1%) of deaths attributable to cardiovascular disease in the United States. Thus chronic diseases among the American population increase the need for smart medical devices and home-based patient monitoring devices, which drives the studied market growth.

Additionally, most of the major players, such as Garmin Ltd, Fitbit, Inc, and Biotelemetry, Inc, in the studied market are concentrated in this region and have been investing in the research and development of smart medical devices launching innovative products in this region. For instance, in August 2020, Fitbit, Inc launched Fitbit Sense, an advanced health smart watch that helps detect the body's responses to stressors by measuring electrodermal activity responses. Thus, in view of the facts, the studied market is expected to grow significantly in North America over the forecast period.

Smart Medical Devices Market Competitor Analysis

The smart medical devices market is moderately competitive, and few companies hold most of the market share. New players are coming up in the market due to the technological advancements in the healthcare industry and the rising R&D expenditure of the companies. Some of the companies which are currently dominating the market are Abbott laboratories, apple inc, Bio-beat, Dexcom Inc, F. Hoffmann la Roche Ltd, Fitbit Inc, Medtronic plc, Neurometric Inc, Omron Corporation, Otsuka Holdings Co., Ltd, Koninklijke Philips N.V., Vital Connect, Samsung and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Demand for Smartphone-compatible and Wireless Medical Devices
    • 4.2.2 Technological Advancement in Devices
    • 4.2.3 Rising Awareness and Focus on Fitness
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Devices
    • 4.3.2 Patients Privacy Concerns
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 By Diagnostic and Monitoring
      • 5.1.1.1 Blood Glucose Monitors
      • 5.1.1.2 Heart Rate Monitors
      • 5.1.1.3 Pulse Oximeters
      • 5.1.1.4 Blood Pressure Monitors
      • 5.1.1.5 Breath Analyzer
      • 5.1.1.6 Other Diagnostic Monitoring Products
    • 5.1.2 By Therapeutic Devices
      • 5.1.2.1 Portable Oxygen Concentrators and Ventilators
      • 5.1.2.2 Insulin Pumps
      • 5.1.2.3 Hearing Aid
      • 5.1.2.4 Other Therapeutic Devices
  • 5.2 By End User
    • 5.2.1 Hospitals/Clinics
    • 5.2.2 Home-care Setting
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Apple Inc.
    • 6.1.3 BIO-BEAT
    • 6.1.4 Dexcom Inc.
    • 6.1.5 F. Hoffmann-La Roche Ltd
    • 6.1.6 Fitbit Inc.
    • 6.1.7 Medtronic PLC
    • 6.1.8 NeuroMetrix Inc.
    • 6.1.9 Omron Corporation
    • 6.1.10 Otsuka Holdings CO. LTD
    • 6.1.11 Koninklijke Philips N.V.
    • 6.1.12 Vital Connect
    • 6.1.13 Samsung

7 MARKET OPPORTUNITIES AND FUTURE TRENDS